Evaluation of mucinous carcinoma associated antigen (MCA) levels in patients with breast cancer

Chu TM , Nemoto T. Evaluation of carcinoembryonic antigen in human mammary carcinoma. JNCI 1973; 51: 1119–22.

Sthali C , Takaes B , Miggiano V , Staehelin T , Carmann H. Monoclonal antibodies against antigens on breast cancer cells. Experientia 1985; 41: 1377–81.

Bombardieri E , Gion M , Mione R , Dittadi R , Bruscagnin G , Buraggi GL . A mucinous-like carcinoma-associated antigen (MCA) in the tissue and blood of patients with primary breast cancer. Cancer 1989; 63: 490–5.

Sthali C , Caravatti M , Aeschbacher M , Kocyba C , Takaes B , Carmann H. Mucinlike carcinoma-associated antigen defined by three monoclonal antibodies against different epitopes. Cancer Res 1988; 48: 6799–802.

Eskelinen M , Tikanoja S , Valkamo E , Mucinous carcinoma associated antigen (MCA) in breast tumors. Proceedings 5th International Conference (IATMO): Tumor Markers in Cancer Diagnosis and Therapy. Stockholm, September 1988.

Molina R , Filella X , Mengual P , Balague A , Ballesta AM . Evaluation of a new tumor marker: MCA. Proceedings XVI International I.S.O.B.M. Congress. Barcelona, September 1988.

Thomas CMG , Wobbes TH , Segers MFG , Bruggink EDM , Verbeek ALM . Combination of preteatment serum levels of MCA, CA 15–3, SCC, TPA and CEA in patients with mammary carcinoma. Proceedings XVI International I.S.O.B.M. Congress. Barcelona, September 1988.

Kallioniemi OP , Oksa H , Aaran RK , Hietanen T , Lehtinen M , Koivula T. Serum CA 15–3 assay in the diagnosis and follow-up of breast cancer. Br J Cancer 1988; 58: 213–5.

Pecchio F , Coluccia C , Moscato D , MCA: a new marker in breast carcinoma: comparison with CEA, TPA and CA 15–3. Proceedings XVI International I.S.O.B.M. Congress. Barcelona, September 1988.

Molina R , Filella X , Mengual P , Balague A , Ballesta AM . MCA in breast cancer. Proceedings XVI International I.S.O.B.M. Congress. Barcelona, September 1988.

Thomas CMG , Wobbes TH , Segers MFG , Bruggink EDM , Verbeek ALM . Pretreatment serum levels of MCA, CA 15–3, SSC, TPA and CEA in patients with mammary carcinoma. Proceedings XVI International I.S.O.B.M. Congress. Barcelona, September 1988.

Cooper EH , Forbes MA , Hancock AD . An evaluation of MCA in breast cancer. Proceedings XVI International I.S.O.B.M. Congress. Barcelona, September 1988.

Caravatti M , Mauer A , Hegi T , Muller J , Hoffmann F. Clinical value of the new tumor marker MCA in the monitoring of breast cancer patients. Proceedings 5th International Conference (IATMO): Tumor Markers in Cancer Diagnosis and Therapy. Stockholm, September 1988.

Bieglmayer C , Szepesi T , Neunteufel W. Follow-up of metastatic breast cancer patients with a mucin-like carcinoma-associated antigen: comparison to CA 15–3 and carcinoembryonic antigen. Cancer Lett 1988; 42: 199–206.

Sersa G , Plesnicar S , Prosen M , Novakovic S. MCA levels in breast cancer in patients in different stages of the disease. Proceedings 5th International Conference (IATMO): Tumor Markers in Cancer Diagnosis and Therapy. Stockholm, September 1988.

Van Dalen A. CEA, CA 15–3 and MCA in the serum of breast cancer patients. Proceedings XVI International I.S.O.B.M. Congress. Barcelona, September 1988.